arrow
Back
O

Oliver Sartor

University Medical Center Hamburg-Eppendorf

95H-index
1.3KPaper Count
4.5WCitation Count
Published Papers 301
Publication Date
Chromosomal instability in circulating tumor cells and cabazitaxel resistance in metastatic castration-resistant prostate cancer
err2025-12-22
err0
errOAAI
errLongoria, Ossian; Rekowski, Jan; Gupta, Santosh; Beije, Nick; Pantel, Klaus; Efstathiou, Eleni; Sternberg, Cora; Castellano, Daniel; Fizazi, Karim; Tombal, Bertrand; Sharp, Adam; Sartor, Oliver; Mace, Sandrine; Geffriaud-Ricouard, Christine; Wenstrup, Richard; De Wit, Ronald; De Bono, Johann
errShare
errSave
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
errShare
errSave
Resisting RECIST: PSMA PET and Regulatory Change in Prostate Cancer
err2025-11-01
err0
PREAI
errSartor, Oliver; Emmett, Louise; Herrmann, Ken
errShare
errSave
PROSTest, a Multigene Liquid Biopsy Signature, Effectively Stratifies Patients With High PSA for Prostate Biopsy
err2025-09-01
err0
PREAI
errRahbar, Kambiz; Rosin, R. David; Kidd, Mark; Halim, Abdel B.; Sartor, Oliver
errShare
errSave
Outcomes for [177Lu]Lu-PSMA-617 with and Without Concurrent Use of Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration-resistant Prostate Cancer
err2025-08-05
err0
PREAI
errMiguel Muniz; Oliver Sartor; Jacob J. Orme; Regina M. Koch; Zachary Scharf; Elisabeth I. Heath; Jabra G. Zarka; Adam M. Kase; Irbaz B. Riaz; Jack R. Andrews; Matthew P. Thorpe; A. Tuba Kendi; Gokce Belge Bilgin; Geoffrey B. Johnson; Eugene D. Kwon; Daniel S. Childs
errShare
errSave
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer
err2025-07-19
err0
PREAI
errSoumyajit Roy; Yilun Sun; James A. Eastham; Martin Gleave; Christopher J.D. Wallis; Himisha A. Beltran; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Himanshu Nagar; Jorge A. Garcia; Eric J. Small; Paul Nguyen; Gerhardt Attard; Rana R. McKay; Oliver Sartor; Alejandro Berlin; Seth A. Rosenthal; Susan Halabi; Randy Vince; Lee Ponsky; Scott C. Morgan; Raquibul Hannan; Adam Raben; Mack Roach; Jeff M. Michalski; Michael J. Morris; Howard M. Sandler; Daniel E. Spratt
errShare
errSave
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial
err2025-07-17
err0
errOAAI
errRyan M. Phillips; James A. Proudfoot; Elai Davicioni; Yang Liu; Daniel E. Spratt; Jeff M. Simko; Robert B. Den; Alan Pollack; Seth A. Rosenthal; A. Oliver Sartor; Christopher J. Sweeney; Gerhardt Attard; Leslie Longoria; Samir Patel; Michael W. Straza; Jason A. Efstathiou; Amit B. Shah; Karen E. Hoffman; Joseph P. Rodgers; Howard M. Sandler; Felix Y. Feng; Phuoc T. Tran
errShare
errSave
Final overall survival and safety analyses of the phase 3 PSMAfore trial of [177Lu]Lu-PSMA-617 versus change of androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer
err2025-07-17
err0
errOAAI
errK. Fizazi; K.N. Chi; N.D. Shore; K. Herrmann; J.S. de Bono; D. Castellano; J.M. Piulats; A. Fléchon; X.X. Wei; H. Mahammedi; G. Roubaud; M. Fleming; T. Haas; S. Ghebremariam; T.N. Kreisl; S. Rajagopalan; O. Sartor; M.J. Morris
errShare
errSave
Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors
err2025-05-03
err0
PREAI
errRegina M. Koch; Miguel Muniz; Candy S. Peskey; Aminah Jatoi; Kathryn J. Ruddy; Jacob J. Orme; Lance C. Pagliaro; Fernando Quevedo; Brian A. Costello; Megan T. Spychalla; Elisabeth I. Heath; Yousef Zakharia; Parminder Singh; Oliver Sartor; Irbaz B. Riaz; Elizabeth J. Cathcart-Rake; Stacy D. D’Andre; Charles L. Loprinzi; Daniel S. Childs
errShare
errSave
Corrigendum to “Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial” [Eur. Urol. 86 (2024) 552–562]
err2025-04-08
err0
errOAAI
errAndrew J. Armstrong; Oliver Sartor; Johann de Bono; Kim Chi; Karim Fizazi; Bernd J. Krause; Ken Herrmann; Kambiz Rahbar; Scott T. Tagawa; Fred Saad; Tomasz M. Beer; Jiwen Wu; Osvaldo Mirante; Michael J. Morris
errShare
errSave
Alkaline phosphatase decline and pain response as predictors of overall survival benefit in patients treated with radium-223: a post hoc analysis of the REASSURE study
err2025-01-09
err0
errOAAI
errO'Sullivan, Joe M.; Heinrich, Daniel; Castro, Elena; George, Saby; Dizdarevic, Sabina; Baldari, Sergio; Essler, Markus; Jong, Igle Jan de; Lastoria, Secondo; Hammerer, Peter G.; Tombal, Bertrand; James, Nicholas D.; Meltzer, Jeff; Sandstrom, Per; Sartor, Oliver
errShare
errSave
Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers
err2024-12-02
err0
errOAAI
errBarnett, Reagan M.; Jang, Albert; Lanka, Sree; Fu, Pingfu; Bucheit, Leslie A.; Babiker, Hani; Bryce, Alan; Meyer, Haley M.; Choi, Yujin; Moore, Casey; Garje, Rohan; Gao, Xin; Kim, Dae Won; Chang, Richard Y.; Gulhati, Pat; Ramaker, Ryne; Bansal, Rani; Zhang, Tian; Oliver Sartor, A.; Armstrong, Andrew J.; Bilen, Mehmet A.; Barata, Pedro
errShare
errSave
Association of Declining Prostate-specific Antigen Levels with Clinical Outcomes in Patients with Metastatic Castration-resistant Prostate Cancer Receiving [177Lu]Lu-PSMA-617 in the Phase 3 VISION Trial
err2024-12-01
err0
errOAAI
errArmstrong, Andrew J.; Sartor, Oliver; de Bono, Johann; Chi, Kim; Fizazi, Karim; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Tagawa, Scott T.; Saad, Fred; Beer, Tomasz M.; Wu, Jiwen; Mirante, Osvaldo; Morris, Michael J.
errShare
errSave
Implementing evidence-based strategies for men with biochemically recurrent and advanced prostate cancer: Consensus recommendations from the US Prostate Cancer Conference 2024
errCANCER
IF5.1
err2024-12-01
err0
PREAI
errBryce, Alan H.; Agarwal, Neeraj; Beltran, Himisha; Hussain, Maha H.; Sartor, Oliver; Shore, Neal; Antonarakis, Emmanuel S.; Armstrong, Andrew J.; Calais, Jeremie; Carducci, Michael A.; Dorff, Tanya Barauskas; Efstathiou, Jason A.; Gleave, Martin; Gomella, Leonard G.; Higano, Celestia; Hope, Thomas A.; Iagaru, Andrei; Morgans, Alicia K.; Morris, David S.; Morris, Michael J.; Petrylak, Daniel P.; Reiter, Robert E.; Rettig, Matthew B.; Ryan, Charles J.; Sellinger, Scott B.; Spratt, Daniel E.; Srinivas, Sandy; Tagawa, Scott T.; Taplin, Mary-Ellen; Yu, Evan Y.; Zhang, Tian; Mckay, Rana R.; Koo, Phillip J.; Crawford, E. David
errShare
errSave
Outcomes for Patients with Metastatic Castration-Resistant Prostate Cancer and Liver Metastasis Receiving [177Lu]Lu- PSMA-617
err2024-10-30
err0
PREAI
errMuniz, Miguel; Sartor, Oliver; Orme, Jacob J.; Koch, Regina M.; Rosenow, Hana R.; Mahmoud, Ahmed M.; Andrews, Jack R.; Kase, Adam M.; Riaz, Irbaz B.; Bilgin, Gokce Belge; Thorpe, Matthew P.; Kendi, A. Tuba; Johnson, Geoffrey B.; Ravi, Praful; Kwon, Eugene D.; Childs, Daniel S.
errShare
errSave
Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [177Lu] Lu-PSMA-617 therapy: a case report
err2024-10-07
err0
errOAAI
errBilgin, Gokce Belge; Navin, Patrick J.; Johnson, Derek R.; Sartor, Oliver; Kendi, Ayse Tuba
errShare
errSave
Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
err2024-10-03
err0
PREAI
errCalais, Jeremie; Morris, Michael J.; Kendi, Ayse Tuba; Kalebasty, Arash Rezazadeh; Tutrone, Ronald; Anderson, Michael J.; Sartor, Oliver
errShare
errSave
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
errShare
errSave
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial
err2024-10-01
err2
errOAAI
errRoss, Ashley E.; Zhang, Jingbin; Huang, Huei-Chung; Yamashita, Rikiya; Keim-Malpass, Jessica; Simko, Jeffry P.; Devries, Sandy; Morgan, Todd M.; Souhami, Luis; Dobelbower, Michael C.; Mcginnis, L. Scott; Jones, Christopher U.; Dess, Robert T.; Zeitzer, Kenneth L.; Choi, Kwang; Hartford, Alan C.; Michalski, Jeff M.; Raben, Adam; Gomella, Leonard G.; Sartor, A. Oliver; Rosenthal, Seth A.; Sandler, Howard M.; Spratt, Daniel E.; Pugh, Stephanie L.; Mohamad, Osama; Esteva, Andre; Chen, Emmalyn; Schaeffer, Edward M.; Tran, Phuoc T.; Feng, Felix Y.
errShare
errSave
Baseline characteristics, safety, and efficacy of Radium-223 in metastatic castration resistant prostate cancer by race: Insights from the REASSURE US subset
err2024-09-21
err0
PREAI
errConti, Peter S.; Sartor, Oliver; Taplin, Mary-Ellen; Song, Daniel Y.; George, Saby; Tomaszewski, Jeffrey; Sylvester, John; Mantz, Constantine; Given, Robert W.; Brookland, Robert; Meltzer, Jeff; Korn, Matthew J.; Andres, Richard; Babajanyan, Svetlana; Higano, Celestia
errShare
errSave